DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
DiaMedica Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 5, 2022
DiaMedica Therapeutics reported fiscal year 2021 executive compensation information on April 5, 2022.
In 2021, three executives at DiaMedica Therapeutics received on average a compensation package of $743K, a 19% increase compared to previous year.
Average pay of disclosed executives at DiaMedica Therapeutics
Rick Pauls, Chief Executive Officer, received $1.1M in total, which increased by 29% compared to 2020. 42% of Pauls' compensation, or $477K, was in salary. Pauls also received $192K in non-equity incentive plan, $452K in option awards, as well as $15K in other compensation.
Scott Kellen, Chief Financial Officer, received a compensation package of $547K, which increased by 12% compared to previous year. 52% of the compensation package, or $286K, was in salary.
Harry Alcorn, Jr., Senior Vice President of Clinical Operations, earned $545K in 2021, a 7% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 5, 2022.